Yi Lu

机构：Suzhou Kowloon Hospital · ORCID：0009-0008-6301-2435

发表论文 8 篇 · 总被引 55 次 · h-index 3

代表论文

• Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer (2022 · BMC Cancer · 被引 36)
• Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma (2021 · Aging · 被引 15)
• Genome-wide methylation and gene-expression analyses in thalassemia (2024 · Aging · 被引 3)
• Loss of Farnesoid X Receptor promotes colorectal liver metastasis via the GutFXR–FGF15–PPARγ–VEGFα–MDSC axis (2026 · Molecular Medicine)
• DPCMHC: efficient prediction of MHC-peptide binding affinity by deep learning based on dual-padding convolution (2025 · bioRxiv (Cold Spring Harbor Laboratory))
• Abstract 1322: The DNA methylation signature of the driver gene GPRASP1 serves as an early indicator of progression in prostate cancer (2025 · Cancer Research)